MAPT and Alzheimer disease: The results showed that SLAB51 probiotics changed the intestinal flora of 3xTg-AD mice, reduced the aggregation and phosphorylation of tau protein, alleviated brain injury, improved cognitive ability, and delayed the progress of AD [39,125].